Opinion
The company views patents and monopolies as necessary ingredients for success, while others suggest the strategy hinders industry growth and innovation.
The past year saw plummeting valuations for psychedelic companies, a late comeback for stock values, emerging methodical challenges in clinical trials, and some organizations’ strategic – but contested – move away from psychedelia’s “cultural baggage.”
A new research project aims to destigmatize long lasting negative psychedelic experiences and investigate support methods.
While there is reason to celebrate any drug policy reform victory, Coloradans need to be aware of the unique risks particular to ibogaine.
Harm reduction may be the answer, but D.A.R.E. programs are still active in 75 % of U.S. school districts and in more than 43 countries.
Data is essential for the expansion of services, but it must be implemented in a way that protects both client and facilitators.
It behooves anyone who intends to work as a psychedelic guide to have psychedelic experience; you’re either on the bus or you’re not.
In this interview, Firefly VR founder Shel Mann discusses how immersive technology can help prepare patients for psychedelic therapies, and the integration of virtual tools into mainstream healthcare.
The therapeutic benefits of psychedelic medicines may not require the psychoactive effects.
The early results of a COMPASS Pathways clinical trial quell some concerns related to the safety of psychedelic therapy for individuals with bipolar disorder.
